Thomas Allen Crozier

Thomas Allen Crozier

Auto-generated profile, based on publicly available information

Thomas Allen Crozier

Department of Anaesthesiology, Emergency and Intensive Care Medicine, University of Göttingen Medical School, Robert-Koch Str. 40, 37075 Göttingen, Germany

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2009 in BMC Clinical Pharmacology
Verified
Journal Article
Open access
PDF file
GPGoran Pavlaković
Goran Pavlaković
JTJulija Tigges
Julija Tigges
TCThomas A Crozier
Thomas A Crozier
Buspirone is a partial 5-HT1A receptor agonist. Animal studies have shown that modulation of serotoninergic transmission at the 5-HT1A receptor can induce analgesia in acute pain models. However, no studies have been published so far on the effects of serotonin receptor agonists on pain perception in humans.

20 November 2008 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
TCThomas A. Crozier
Thomas A. Crozier
DKDesiree Karimdadian
Desiree Karimdadian
SHSvenja Happe
Svenja Happe
The restless legs syndrome (RLS) is a common sensorimotor disorder of unknown cause affecting approximately 10% of the population.1 One uncontrolled study showed that spinal anesthesia caused postoperative RLS.2 We conducted a prospective study to determine whether the occurrence of postoperative RLS was associated with the type of anesthesia.

1 December 2006 in European Journal of Anaesthesiology
Verified
Journal Article
Closed access
TCThomas A Crozier
Thomas A Crozier

18 January 2015 in BMC Anesthesiology
Verified
Journal Article
Open access
PDF file
IBIngo Bergmann
Ingo Bergmann
TSTorsten Szabanowski
Torsten Szabanowski
ABAnselm Bräuer
Anselm Bräuer
TCThomas A Crozier
Thomas A Crozier
Martin BauerMartin Bauer
Martin Bauer
JHJosé Maria Hinz
José Maria Hinz
Even extremely high-doses of the potent opioid, sufentanil, cannot reliably suppress stress responses to intense surgical stimuli such as sternotomy. The chemically related opioid remifentanil with its different pharmacokinetics and binding affinities for delta- and kappa-opioid receptors might be more effective in attenuating these responses.

4 January 2014 in BMC Anesthesiology
Verified
Journal Article
Open access
PDF file
IBIngo Bergmann
Ingo Bergmann
TCThomas Allen Crozier
Thomas Allen Crozier
MRMarkus Roessler
Markus Roessler
HSHanna Schotola
Hanna Schotola
AMAshham Mansur
Ashham Mansur
Martin BauerMartin Bauer
Martin Bauer
The conventional sequence when using supraglottic airway devices is insertion, cuff inflation and fixation. Our hypothesis was that a tighter fit of the cuff and tip could be achieved with a consequently lower incidence of air leak, better separation of gastrointestinal and respiratory tracts and less airway morbidity if the device were first affixed and the cuff then inflated.

1 January 1999
Verified
Journal Article
Closed access
TCT. A. Crozier
T. A. Crozier
DKD. Kietzmann
D. Kietzmann
BDB. Döbereiner
B. Döbereiner
There are anecdotal reports of dysphoria occurring in patients on the first day after anaesthesia with remifentanil. This study was performed to investigate this allegation and to find a possible relationship to postoperative shivering or to nausea and vomiting. Patients undergoing otorhinolaryngeal surgery took part in a prospective, randomized, double-blind study comparing total intravenous anaesthesia with propofol (2 mg kg(-1) bolus injection then 100 microg kg(-1) min(-1)) and remifentanil (1 microg kg(-1) bolus then 0.1-0.5 microg kg(-1) min-1) or alfentanil (30 microg kg(-1) bolus then 0.16-0.83 microg kg((-1) min(-1)). The patients were carefully insulated and actively warmed by convective heating and rectal temperature was monitored continuously. Postoperative shivering was graded on a three-point scale, and the cumulative incidence of nausea and vomiting were registered at 24 h after surgery. Pre- and postoperative mood was measured with the von Zerssen mood scale (Befindlichkeits-Skala) and changes tested for significance. High scores reflect discontent and dysphoria. The data of 98 patients (49 in each group, ASA I-II, age 42 +/- 13 yr, anaesthesia time 141 +/- 60 min; mean +/- SD; intergroup P values > 0.1) were evaluated. Core temperature did not change perioperatively (before 36.6 +/- 0.2 degrees C; after 36.8 +/- 0.3 degrees C, inter- and intragroup P > 0.1). The incidence of nausea was the same in each group; vomiting occurred with equal frequency (6/49 vs. 7/49). Shivering was significantly more frequent after remifentanil (41% vs. 10%, P < 0.001). The patients' mood remained stable after remifentanil but worsened after alfentanil (von Zerssen score from 9.3 +/- 2.5 to 13.9 +/- 3.6; mean +/- 95% confidence intervals; P < 0.01). Postoperative shivering was more frequent after remifentanil but was unrelated to intraoperative heat loss. Contrary to preliminary informal observations, there was no evidence that remifentanil caused postanaesthetic dysphoria on the day one after surgery.